Achieve Life Sciences, Inc.
ACHV
$5.10
$0.255.16%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -33.95% | 15.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.97% | 0.27% | |||
| Operating Income | 28.97% | -0.27% | |||
| Income Before Tax | 30.65% | -1.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.65% | -1.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.65% | -1.53% | |||
| EBIT | 28.97% | -0.27% | |||
| EBITDA | 29.09% | -0.25% | |||
| EPS Basic | 30.78% | 2.79% | |||
| Normalized Basic EPS | 28.30% | 2.79% | |||
| EPS Diluted | 30.78% | 2.79% | |||
| Normalized Diluted EPS | 28.30% | 2.79% | |||
| Average Basic Shares Outstanding | 0.20% | 4.43% | |||
| Average Diluted Shares Outstanding | 0.20% | 4.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||